SCHEMBL2648484

SCHEMBL2648484

Cc1ccc(SCc2c(C(C)C)nc(C(C)C)c(CO)c2-c2ccccc2O)cc1

nearest known ligand 0.61

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GCGR P47871 20/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2647763 0.91 GCGR (0.56) GCGR
SCHEMBL2648473 0.90 GCGR (0.57) GCGR
SCHEMBL2647761 0.87 GCGR (0.64) GCGR
SCHEMBL2647112 0.86 GCGR (0.64) GCGR
SCHEMBL2647889 0.85 GCGR (0.62) GCGR
SCHEMBL2647474 0.84 GCGR (0.44) GCGR
SCHEMBL2647055 0.83 GCGR (0.63) GCGR
SCHEMBL2647529 0.81 GCGR (0.53) GCGR
SCHEMBL2649325 0.81 GCGR (0.61) GCGR
SCHEMBL2648753 0.80 GCGR (0.64) GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218431-B1 GLUCAGON RECEPTOR ANTAGONISTS FOR THERAPY OF DIABETES AND CONDITIONS ASSOCIATED WITH DIABETES BAYER CORPORATION 2001-04-17 US disclosed
EP-0934274-A1 SUBSTITUTED PYRIDINES AND BIPHENYLS AS ANTI-HYPERCHOLESTERINEMIC, ANTI-HYPERLIPOPROTEINEMIC AND ANTI-HYPERGLYCEMIC AGENTS Bayer Corporation (US) 1999-08-11 EP disclosed
WO-1998004528-A2 SUBSTITUTED PYRIDINES AND BIPHENYLS AS ANTI-HYPERCHOLESTERINEMIC, ANTI-HYPERLIPOPROTEINEMIC AND ANTI-HYPERGLYCEMIC AGENTS BAYER CORPORATION (US) 1998-02-05 WO disclosed